Ketamine for OUD and Suicidal Ideation in the ED

Summary

This is a pilot, double-blind, placebo-controlled randomized clinical trial of individuals with opioid use disorder (OUD) with suicidal ideation in the emergency department (ED) to receive either a single infusion of ketamine 0.8mg/kg (n=25) or saline placebo (n=25). The primary aim is to evaluate the safety of the ketamine treatment. The secondary aim is to determine the preliminary efficacy of opioid- and suicide-related outcomes.

Timeline

Start

2024-06-14

Primary completion

2025-03-11

Completion

2025-03-31

Outcome

Outcome not reported

Stopped (Enrollment): “Low recruitment numbers and study funding will be closing shortly.”

Drugs

Indications